Pharmaceutical Industries' Achievements of the 11th Government Introduced

The achievements of the country's pharmaceutical industries were introduced in an event held on Saturday, May 21st 2016 in the Pharmaceutical Development center of the Medical University of Tehran, with the presence of Eshaq Jahangiri, First Deputy of President, Dr. Seyed Hassan Hashemi, Minister of Health Medical Education and Dr. Rasool Dinarvand, chairman of the Food and Drug Administration. Concurrent with this ceremony, the Unit of Producing Recombinant Drug Material was inaugurated.

In this event, 70 drug items that were incorporated during the 11th government were introduced, News Agency reported. These drugs are used for treating different diseases such as MS, neurological and psychological diseases and cancer and are mostly manufactured by knowledge-based companies in order to realize resistive economy and currency optimization.

Dr. Seyed Hassan Hashemi stated that: "At the beginning stages of the 11th government, we were facing pharmaceutical crisis, in a way that 300 articles of drugs were in shortage; but today, this number has diminished to less than 30 drugs and the public's access to drugs has been provided all over the country."

Saying that people used to pay 40 percent of the their expenses for medicine and medical equipment, he added: "Today this number has decreased to 5 percent. People from rural areas pay as low as 3 percent of their medicinal and medical equipment expenses, while this number is 6 percent for people living in cities."

Announcing that prior to the implementation of the Health System Evolution Plan, 90 percent of people's attending for obtaining medicine and medical equipment was outside medical centers, Minister of Health continued: "Currently, the number of references for obtaining medicine and medical equipment to outside medical centers has reached a percentage of less than 3."

Stating that the 11th government is being accused that by implementing the Health System Evolution Plan, it wants to increase pharmaceuticals importations, Hashemi explained: "In 2012, we had one billion, 350 million dollars pharmaceuticals importation, while this number has diminished to a range below one billion."

He also announced that the pharmaceuticals' share of exports has been doubled and added: "Today's issue of our pharmaceutical industry is its outdatedness."

He then said: "If the government were able to aid our pharmaceutical industry in the amount of one thousand billion tomans, we will be able to seize a great share of regional markets within the next 5 to 10 years."

Stating that since the beginning of the 11th government's term, each month, two drugs have been incorporated to the pharmaceutical market, Dr. Hashemi added: "During this government's term, more than 60 drugs have been produced and distributed for the first time."

Es'haq Jahangiri then added: "Efficiency is the biggest lost chain in Iran's economy."

Stating that in many countries of the world, the major share of the economic growth is resulted by increase in efficiency, he added: "Unfortunately, our country is in the worst situation in terms of efficiency, in a way that it has been repeatedly stated in the Third Development Plan that 33 percent of the economic growth must be from efficiency, while this number still stays at 0."

Pointing to the Prospect Document and its prediction of 8 percent growth, Jahangiri said that: "2.5 units of this 8 percent growth are supposed to come from efficiency."

Stressing on the fact that this lack of efficiency must be eliminated from Iran's economy, First Deputy of the President stated that: "To leave this situation, we need plans and objectives to reach efficient."

He then pointed to the pharmaceutical industry and said: "Quality and cost are the most important subjects that should be put into consideration in order to incorporate Iranian products to international markets."

Jahangiri spoke of the Health System Evolution Plan as the most important key achievement of the 11th government and added that: "We will not forget the status we were in prior to the 11th government in terms of health."

President's First Deputy confessed possible shortcomings and issues with the Health System Evolution Plan that should be adjusted and then continued: "To manufacture two new drugs per month is a source pride for the country."

Pointing out the capabilities of the country's researchers and scientists in the field of pharmaceutical industries, he stressed: "We must have a development center next to each university, so that the ideas are turned into products."

Jahangiri also insisted on supporting the private sector in the pharmaceutical industry and stated: "The private sector is able to take over the responsibility of production."

150 Million Exports is not Worthy of Iran

Dr. Rasool Dinarvand, chairman of Food and Drug Administration stated that: "Today is a very good day for the country's pharmaceutical industry."

Pointing to the year 2016, as the year of resistive economy, he stressed: "Resistive economy is derived from knowledge-based economy, in a way that with the support of the government and investing on the elite and researchers, we can prevent the immigration of these people from our country and realize the stages of growth in the pharmaceutical industry."

Dinarvand mentioned the pharmaceutical industry's work during the 11th government and said: "The pharmaceutical industry has been successful in this government in a way that together with limiting imports and reducing currency dependency, we have been witnessing the flourishment of pharmaceuticals production within the country."

He also spoke of controlling people's expenses for procuring medicine and medical equipment as another achievement by the 11th government in the health field and said: "The priority for the Ministry of Health is to open the gates for exports."

Chairman of the Food and Drug Administration announced that exports in the amount of 150 million dollars is not worthy of this country and stated: "This amount of exports, against one billion dollars of import is not acceptable."

Dinarvand announced the objectives to reach a positive balance in pharmaceuticals export and import in the 2025 Landscape and said: "Our planning for reaching a positive balance in the year 2025 is already on track."

He also spoke of the plans of the Ministry of Health for supporting knowledge-based companies in the field of exporting medicine and added that: "We have enacted that for each million dollar worth of pharmaceuticals exports, these companies will be given grants for drug manufacturing in three months ahead of schedule."

Chairman of the Food and Drug Administration considered attention to domestic market and limiting imports as one of the issues of our country's pharmaceutical industry and stated: "By exporting pharmaceuticals, we can export the outcome of our knowledge."

In the end, Dr. Ali Jaafarian, Chancellor of Tehran's University of Medical Sciences said: "Fourteen molecules of medicinal doze have been manufactured in the pharmaceutical development center of this university, with 22 of them dated to the year 2015; furthermore, the majority of these drugs are considered to be anti-cancer and expensive imported medicine." Jaafarian also committed to incorporate 10 new pharmaceutical peptidyl products to the market.